The low drop out rate is unambiguously good news. It is healthy in general terms to have a cynical perspective on ASX biotech announcements but in this case it is misplaced!
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025